Delivery Order SPE2DB22D2214-SPE2DB25FS6SF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Apretude ER 600 mg/3 ml vials with a ceiling value of $4,777.92. This is a firm fixed-price delivery order with an ultimate completion date of July 11, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The award utilized no set-aside provisions and was competitively awarded through open competition. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,777.92 delivery order to AmerisourceBergen Drug Corp for the supply of Apretude ER 600 mg/3 ml vials. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Apretude ER 600 mg/3 mL vials. This firm fixed-price delivery order, valued at $2,388.96, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle designated SPE2DX and active through December 2026. The award was made through open...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,022.44 to AmerisourceBergen Drug Corp on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $83,314.98 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,672.43 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division. The contract will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. As a child order under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,520.39 by the Defense Logistics Agency's Medical Supply Chain on September 21, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract valued at $1,892.95 from the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. This firm fixed-price delivery order carries an ultimate completion date of August 22, 2025, and represents a non-set-aside, competitively awarded contract. The contract serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.17 to AmerisourceBergen Drug Corp on September 11, 2025, with an ultimate completion date of September 12, 2025. The order is for pharmaceutical products identified as "4569424878 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" under a firm fixed price contract type with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6SFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,388.96 to AmerisourceBergen Drug Corp for the supply of Apretude ER 600 mg/3 mL vials on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through open competition. This delivery order for Apretude contributes to the Defense Logistics Agency's pharmaceutical supply chain supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/25/25 |